View Document Preview and Link Document Date: 2010-01-08 13:40:17 Open Document File Size: 272,47 KB Share Result on Facebook
Company Patient Care Facilities / 3M / / Country United States / / Event FDA Phase / Product Issues / / Facility Hospital Discharge / Each facility / National Institute / / IndustryTerm healthcare facility / personal respiratory protective equipment / healthcare provider staff / transportation vehicles / transportation settings / healthcare / protected healthcare workers / Healthcare facilities / healthcare workers / transportation setting / train healthcare workers / healthcare settings / personal protective equipment / healthcare providers / healthcare setting / screen healthcare workers / / MedicalCondition TB / infectious droplet nuclei / HIV / M. tuberculosis / infectious cases / infectious droplet nuclei It / TB disease / airborne infection / infectious TB disease coughs / TB infection / Tuberculosis infection / sneezes / Hepatitis / infectious TB disease / Drug-susceptible tuberculosis disease / Multidrug-resistant tuberculosis disease / infectious droplet nuclei Ultraviolet / infectious patient releases / disease / communicable diseases / Mycobacterium tuberculosis / In TB infection / latent TB infection / facility’s TB infection / infection / infectious disease / Tuberculosis / infectious tuberculosis / / MedicalTreatment counseling / / Organization Nevada State Health Division / Infectious Diseases Society of America / National Institute for Occupational Safety and Health / Health and Safety Administration / Centers for Disease Control and Prevention / American Thoracic Society / Occupational Health and Safety Administration / / Position Counsel / administrator / / Product Nokia N95 Smartphone / air Exhausts / N-95 / air / / ProvinceOrState Nevada / / RadioStation 2.15 When / 2.16 When / 2.09 Who / / URL http / SocialTag 
Infection Control CONTENTS Introduction ............................................. 2.2 Purpose................................................................ 2.2 Policy ...............................................